Pregled bibliografske jedinice broj: 480986
Sinteza i ispitivanje citostatskih djelovanja pirimidinskih i purinskih derivata L-askorbinske kiseline
Sinteza i ispitivanje citostatskih djelovanja pirimidinskih i purinskih derivata L-askorbinske kiseline // Drugs of the Future / J. Prous, Jr. (ur.).
Barcelona: Thomson Reuters, 2010. (poster, nije recenziran, sažetak, znanstveni)
CROSBI ID: 480986 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Sinteza i ispitivanje citostatskih djelovanja pirimidinskih i purinskih derivata L-askorbinske kiseline
(Synthesis and cytostatic activity evaluation of pyrimidine ad purine derivatives of L-ascorbic acid)
Autori
Wittine, Karlo ; Stipković Babić, Maja ; Kraljević Pavelić Sandra ; Pavelić Krešimir ; Mintas Mladen
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Drugs of the Future
/ J. Prous, Jr. - Barcelona : Thomson Reuters, 2010
Skup
EFMC-ISMC 2010 XXIst INTERNATIONAL SYMPOSIUM ON MEDICINAL CHEMISTRY
Mjesto i datum
Bruxelles, Belgija, 05.09.2010. - 09.09.2010
Vrsta sudjelovanja
Poster
Vrsta recenzije
Nije recenziran
Ključne riječi
pirimidinske baze; L-askorbinska kiselina; citostatska ispitivanja
(pyrimidine bases; L-ascorbic acid; cytostatic activity evaluation)
Sažetak
Nucleoside analogues represent a valuble source that contributes significantly to the arsenal of chemotherapeutic agents against viruses and cancer. The principal aim of this study was to synthesize the new nucleoside congeners in which the sugar ring was substituted with L-ascorbic acid moiety and to evaluate their cytostatic activity potency. L-ascorbic acid itself has been found to be cytotoxic to some human tumor cells, neuroblastoma1, osteosarcoma and retinoblastoma.2 Ascorbic acid and ascorbyl esters have been found to inhibit the proliferation of mouse glioma and human brain tumor cells, glioma (U-373) and glioblastoma (T98G) cells and renal carcinoma cells.3, 4 In addition to that we have demonstrated that pyrimidine and purine derivatives of L-ascorbic acid exert cytostatic activity against malignant cell lines, especially leukemia (IC50 = 0.9 M) and murine mammary carcinoma (IC50 = 1.4 M), as well as other malignant tumor cell lines.5 Based on this finding we have synthesized a series of pyrimidine (1-12) and purine (13-15) derivatives of L-ascorbic acid containing the free hydroxy group (7-9) at C-5 of ethylenic spacer or amino group at C-4 position (5, 6, 10-15) of the lactone ring and evaluated their cytostatic potential.
Izvorni jezik
Engleski
Znanstvena područja
Kemija
POVEZANOST RADA
Projekti:
125-0982464-2922 - RAZVOJ NOVIH PROLIJEKOVA I LIJEKOVA PROTIV VIRUSA I RAKA (Mintas, Mladen, MZOS ) ( CroRIS)
Ustanove:
Fakultet kemijskog inženjerstva i tehnologije, Zagreb
Profili:
Maja Stipković Babić
(autor)
Krešimir Pavelić
(autor)
Mladen Mintas
(autor)
Karlo Wittine
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus